Previous studies demonstrated that CASC19 was involved in clear cell renal cell carcinoma (ccRCC) [33], non-small cell lung cancer (NSCLC) [34], glioma [35], and pancreatic cancer [36]. The gene discussed is CASC19; the disease is central nervous system cancer.